Feraccru is a unique, non-salt, formulation oral iron: strong efficacy with “placebo-like” tolerability Potential to change iron deficiency anaemia (IDA) therapeutic algorithm Feraccru to become the preferred option for patients not...

Shield Therapeutics PLC

Shield Therapeutics PLC

Shield Therapeutics is a high potential, commercial stage specialty-pharma company. We pride ourselves on providing solutions to unmet medical needs and delivering value to our shareholders.

Market: LSE
52-week High/Low:
Sector: Pharma & Biotech
Market Cap: 58.80M

Popular Content

Tag Content

Shield Therapeutics PLC Timeline